However, the contradictory result from Yang’s research comes out that E2-induced PI3K/Akt pathway activation promotes the expression of PD-L1 by post-transcriptional control and inhibits the anti-tumor function of T cell in ER+ breast cancer [69]. Here, AKT1 is linked to breast carcinoma.